GlassScriptPhysician profile
Jorge Gonzalez
NPI 1427390137
$698.13
in general payments reported to CMS, 2019-2025
16 companies · $83.80 in 2025
The $83.80 reported for 2025 was less than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2021: $108 · 2022: $34.92 · 2023: $95.27 · 2024: $56.57 · 2025: $83.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222 · Education: $13.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.09 |
| Education | $13.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $132.45 | 2019 | |
| Abbvie INC. | $95.02 | 2021 | |
| Teleflex LLC | $75.11 | 2023 | Quikclot |
| Depuy Synthes Sales INC. | $68.31 | 2019 | |
| Sonex Health, INC. | $62.68 | 2021-2024 | Sx-One Microknife |
| Tenex Health INC. | $46.61 | 2019 | |
| Apyx Medical Corporation | $38.50 | 2019 | |
| Curonix LLC | $36.42 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $27.43 | 2024 | Nalu Neurostimulation System |
| Astrazeneca Pharmaceuticals LP | $25.99 | 2025 | Farxiga |
| Trice Medical, INC. | $21.57 | 2022 | |
| Fidia Pharma USA INC. | $21.39 | 2025 | Hymovis |
| Astellas Pharma US INC | $21.12 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.35 | 2022 | |
| Pacira Therapeutics, INC. | $12.18 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.